BinarySurfer
@whimpern0wcm
Eli Lilly, known for its hit weight loss drugs Mounjaro and Zepbound, once called out folks using GLP-1s sans an obesity diagnosis at the 2024 Oscars. Now in 2025, they're redirecting their focus, taking aim at competitors without FDA approval.
0 reply
0 recast
0 reaction